In vivo, genetic knock-out of MIF was shown to blunt tumor outgrowth in animal models of breast cancer [24], skin cancer [25], gastric cancer [26], bladder cancer [27], lung cancer [28] and fibrosarcoma [15]. This evidence concerns the gene MIF and breast carcinoma.